日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19

新冠肺炎康复患者体内中和抗体的演变及其对不同SARS-CoV-2变种的交叉活性

Liu, Wang-Da; Wang, Jann-Tay; Chao, Tai-Ling; Ieong, Si-Man; Tsai, Ya-Min; Kuo, Po-Hsien; Tsai, Ming-Jui; Chen, Yi-Jie; Li, Guei-Chi; Ho, Shu-Yuan; Chen, Hui-Hou; Huang, Yu-Shan; Hung, Chien-Ching; Chen, Yee-Chun; Chang, Sui-Yuan; Chang, Shan-Chwen

Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval

异源ChAdOx1-nCoV-19/mRNA-1273初免-加强免疫接种(间隔12周)的血清学应答和安全性

Sheng, Wang-Huei; Chang, Sui-Yuan; Hsieh, Ming-Ju; Ieong, Si-Man; Chang, Shan-Chwen

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

台湾意外接种未稀释BNT162b2新冠疫苗初剂的受试者的安全性和抗体反应

Sheng, Wang-Huei; Wang, Chung-Cheng; Chu, Ching-Chi; Lin, Yueh-Juh; Chang, Sui-Yuan; Ieong, Si-Man; Chang, Shan-Chwen

Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine.

在先前接种过两剂 ChAdOx1 疫苗的健康成年人中,第三剂 mRNA COVID-19 疫苗的免疫原性和安全性

Sheng Wang-Huei, Ieong Si-Man, Lin Pin-Hung, Hsieh Ming-Ju, Yang Hung-Chih, Pan Ching-Fu, Chao Tai-Ling, Chang Sui-Yuan, Chang Shan-Chwen

Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021

2021年7月至8月台湾免疫功能低下患者接种COVID-19 mRNA-1273加强剂后的血清学反应

Lin, Kuan-Yin; Hsieh, Ming-Ju; Chang, Sui-Yuan; Ieong, Si-Man; Cheng, Chien-Yu; Sheng, Wang-Huei; Chang, Shan-Chwen